NCT00300768View on ClinicalTrials.gov

Study Evaluating Orally Administered Moxidectin In Subjects With Onchocerca Volvulus Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

September 6, 2006

Primary Completion Date

November 30, 2009

Study Completion Date

November 29, 2009

Conditions
Onchocerciasis
Interventions
DRUG

2 mg moxidectin

Single-dose, tablet encapsulated for blinding

DRUG

ivermectin 150 mcg/kg

Single-dose, tablets encapsulated for blinding

DRUG

4 mg moxidectin

Single dose, tablets encapsulated for blinding

DRUG

8 mg moxidectin

single dose, tablets encapsulated for blinding

Trial Locations (1)

Unknown

Onchocerciasis Chemotherapy Research Center, Hohoe

All Listed Sponsors
collaborator

World Health Organization

OTHER

lead

Medicines Development for Global Health

OTHER

NCT00300768 - Study Evaluating Orally Administered Moxidectin In Subjects With Onchocerca Volvulus Infection | Biotech Hunter | Biotech Hunter